Iris Lansdorp-Vogelaar
Erasmus MC
Appearances
- DateMay 6, 2023Review updates and current considerations in colon cancer screening and surveillance related topics…
Moderators
Indiana University School of MedicineErasmus MC - DateMay 6, 2023Review updates and current considerations in colon cancer screening and surveillance related topics…
Presenter
Erasmus MC - DateMay 6, 2023Review updates and current considerations in colon cancer screening and surveillance related topics…
Presenters
New York UniversityIndiana University School of MedicineDartmouth-Hitchcock Medical CenterErasmus MC - DateMay 9, 2023In the Dutch colorectal cancer (CRC) screening program, individuals aged 55 to 75 years are invited biennially for fecal immunochemical test (FIT)-based screening using a positivity cut-off of 47 microgram Hemoglobin per gram feces (µg Hb/g)…
- DateMay 9, 2023In the Dutch colorectal cancer (CRC) screening program, individuals aged 55 to 75 years are invited biennially for fecal immunochemical test (FIT)-based screening using a positivity cut-off of 47 microgram Hemoglobin per gram feces (µg Hb/g)…
Presenter
Speakers
- DateMay 6, 2023Colonoscopy surveillance intervals are based on the predicted risk of metachronous colorectal cancer (CRC) after polyp removal. Due to the presence of co-existent findings at baseline colonoscopy, risk estimation per specific polyp subtype is difficult…
Presenter
Speakers
Erasmus MCAcademic Medical Center - DateMay 20, 2024
Presenter
Erasmus MC - DateMay 20, 2024
Presenters
Erasmus MCNew York UniversityAcademic Medical Center - DateMay 21, 2024Gastric cancer (GC) incidence is declining and too low in the US to recommend general population screening. However, the risk of developing GC in the US is substantially higher in ethnic minorities, potentially warranting screening in specific population subgroups. While _H…
Presenter
Speakers
Stanford University School of MedicineErasmus MC - DateMay 21, 2024BACKGROUND: Evidence of gastric cancer (GC) screening’s impact on GC incidence remains limited, hindering the development of health policies for screening programs. We aimed to assess the population impact of organized GC screening programs on GC incidence in Seoul, South Korea…
Presenter
Speakers
Stanford University School of MedicineErasmus MC - DateMay 20, 2024SOCIETY: AGA CP…
Moderators
Erasmus MCFred Hutchinson Cancer Center - DateMay 20, 2024A blood-based colorectal cancer (CRC) screening test may increase screening participation. However, blood-based screening tests may be less effective than current guideline-endorsed options…
Presenter
Speakers
Fred Hutchinson Cancer CenterOregon Health and Science UniversityMemorial Sloan Kettering Cancer Center Department of Epidemiology & BiostatisticsUniversity of Utah School of MedicineErasmus MC - DateMay 20, 2024Blood-based biomarker tests have been developed as a non-invasive colorectal cancer (CRC) screening method to triage patients to colonoscopy…
Presenter
Speakers
Memorial Sloan Kettering Cancer Center Department of Epidemiology & BiostatisticsUniversity of Utah School of MedicineErasmus MCFred Hutchinson Cancer Center - DateMay 20, 2024In 2019, a BMJ Rapid Recommendation panel judged that for adults with a predicted 15-year risk of CRC below 3%, the benefits of colorectal cancer (CRC) screening would not outweigh the burdens and potential harms. The panel recommended against CRC screening for these individuals…
- DateMay 20, 2024Prior studies showed that the benefits, harms, and costs of colorectal cancer (CRC) screening at older ages highly depend on a patient's sex, health, and screening history. However, these studies were not directly informed by stratified data on CRC risk…
- DateMay 20, 2024Most colorectal cancer (CRC) screening programs use a uniform screening strategy. However, it may be more efficient to screen males and females differently due to (ambivalent) biological and demographic differences between the sexes…
- DateMay 20, 2024Colorectal cancer (CRC) screening programmes have been shown effective in reducing CRC incidence and mortality. Risk stratification offers opportunities for further optimisation of screening programmes by better balancing the harms and benefits of screening…
Presenter
Speakers
- DateMay 20, 2024There is growing evidence that the balance between harms and benefits of colorectal cancer (CRC) screening can be improved using risk stratification…
Presenter
Speakers